InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (8 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
8
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the complete record of transactions filed by Wentworth Kory James, Chief Financial Officer. Insider active across 1 company, notably Entrada Therapeutics, Inc.. Cumulatively, 32 filings have been logged. Breakdown: 0 buy · 8 sells. Total volume traded: €378k. History available since 1 March 2022. The latest transaction was filed on 1 April 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Wentworth Kory James
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations32 total
2,500 shares@ US$12.950.011% mcap50.0% of flowCommon StockSEC:0001725663-26-000005:0
5,089 shares@ US$13.001110.7% of flowCommon StockSEC:0001725663-26-000003:0
7,988 shares@ US$12.254915.7% of flowCommon StockSEC:0001725663-26-000002:0
44,600 shares0Common StockSEC:0001725663-26-000001:0
8,910 shares@ US$9.981119.4% of flowCommon StockSEC:0001725663-25-000004:0
1,734 shares@ US$5.43022.5% of flowCommon StockSEC:0001725663-25-000003:0
11,134 shares@ US$2.106.2% of flowCommon StockSEC:0001689375-25-000019:0
1,784 shares@ US$10.675.2% of flowCommon StockSEC:0001689375-25-000016:0
42,400 shares0Common StockSEC:0001689375-25-000014:0
1,000 shares@ US$2.100.6% of flowCommon StockSEC:0001689375-24-000068:0
6,000 shares@ US$2.103.5% of flowCommon StockSEC:0001689375-24-000065:0
3,195 shares@ US$14.97112.8% of flowCommon StockSEC:0001689375-24-000055:0
462 shares@ US$15.76111.9% of flowCommon StockSEC:0001689375-24-000049:0
1,758 shares@ US$14.957.1% of flowCommon StockSEC:0001689375-24-000039:0
9,000 shares@ US$2.105.1% of flowCommon StockSEC:0001689375-24-000017:0
4,086 shares@ US$12.306713.6% of flowCommon StockSEC:0001689375-24-000008:0
30,900 shares0Common StockSEC:0001689375-24-000005:0
2,200 shares@ US$2.101.2% of flowCommon StockSEC:0001689375-23-000077:0
14,200 shares0Common StockSEC:0001689375-23-000064:0
6,116 shares@ US$2.103.4% of flowCommon StockSEC:0001689375-23-000048:0
8,790 shares@ US$2.105.0% of flowCommon StockSEC:0001689375-23-000045:0
17,500 shares@ US$2.109.8% of flowCommon StockSEC:0001689375-23-000044:0
14,200 shares0Common StockSEC:0001689375-23-000028:0
28,400 shares0Common StockSEC:0001689375-23-000015:0
4,550 shares@ US$2.102.7% of flowCommon StockSEC:0001689375-22-000049:0
25 of 32 declarations
About Wentworth Kory James
WENTWORTH KORY JAMES is Chief Financial Officer at Entrada Therapeutics, Inc. He has 32 filings in total. Among the sampled recent filings, they cover the period from 2022-03-03 to 2026-04-02, with EUR 0 in buys and EUR 378165 in sells, and the most frequent transaction nature is Option exercise.
